Last reviewed · How we verify
NCT03332966: YEAH
Youth Experiences and Health Study
trial testing Psychiatric questionnaires in Psychotic Disorders in 1,000 participants. Currently enrolling.
31 December 2024
Quick facts
| Lead sponsor | Finnish Institute for Health and Welfare |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 1 December 2019 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 3 locations across Finland |
Drugs / interventions tested
- Psychiatric questionnaires
- Semi-structured psychiatric interview
Conditions studied
- Psychotic Disorders — all drugs for Psychotic Disorders →
- Psychiatric Hospitalization — all drugs for Psychiatric Hospitalization →
- Prodromal Symptoms — all drugs for Prodromal Symptoms →
- Cannabis Use — all drugs for Cannabis Use →
Sponsor
Finnish Institute for Health and Welfare
Who can join
Adults 15 to 18, any sex, with Psychotic Disorders or Psychiatric Hospitalization. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to identify unusual experiences and psychiatric symptoms that indicate a heightened risk for severe mental disorders - especially psychoses. It is important to develop reliable questionnaire methods that are cost-effective in first-stage screening, leading to in-depth assessments and targeted care. However, existing psychosis-risk questionnaires are limited in content, intended for adults, and have been insufficiently tested for actual predictive value. Therefore we will collect a new, large dataset from an unselected group of adolescents entering psychiatric care in three major urban areas of Finland. Comprehensive national health care registers will be used to assess how well the selected experiences and symptoms predict the participants' mental health over the following few years.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03332966
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Psychotic Disorders
Currently open trials in the same condition.
- NCT07460453 — Racial Disparities in the Expression of Paranoia · NA · recruiting
- NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
- NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting
- NCT07360665 — Multimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Actin · NA · recruiting
- NCT06993662 — The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective. · Phase 1 · active not recruiting
Other Finnish Institute for Health and Welfare trials
Trials by the same sponsor.
- NCT06904469 — Ostrobothnia Digital Clinic Experiment · NA · active not recruiting
- NCT05565170 — Digitally Supported Lifestyle Programme to Promote Brain Health Among Older Adults · NA · active not recruiting
- NCT05117333 — Reminders, Cost Sharing, and Healthcare Use · NA · completed
- NCT03748160 — Herd Immunity and Influenza Vaccine Uptake · NA · completed
- NCT03430180 — Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder · Phase 2 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03332966 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Finnish Institute for Health and Welfare
- Last refreshed: 25 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03332966.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing